Healthy Skepticism Library item: 7245

Warning: This library includes all items relevant to health product marketing that we are aware of regardless of quality. Often we do not agree with all or part of the contents.

Publication type: news

GlaxoSmithKline Reaches Paxil Settlement: GlaxoSmithKline Agrees to $63.8 Million Settlement in Paxil Lawsuit
Yahoo Finance 2006 Nov 1
http://biz.yahoo.com/ap/061101/paxil_lawsuit_settlement.html?.v=3

Abstract:

GlaxoSmithKline PLC has agreed to pay $63.8 million to settle a lawsuit’s claims that it promoted its antidepressant drug Paxil for use by children and adolescents while withholding negative information about the medication’s safety and effectiveness.
Members of the class, including all U.S. residents who bought Paxil and Paxil CR, a controlled-release version of the drug, for their children each could get full refunds if they have records of their purchases. Anyone without such documentation can get $15 returned to them.

As part of the settlement, GlaxoSmithKline denies the lawsuit’s claims, including that consumers paid too much for the drugs, but the world’s second-largest pharmaceutical company wants to resolve the matter to avoid further litigation costs.

Actual payments to consumers will depend on the amount of claims. If there is not enough money to pay all the claims, consumers will get only a portion of the amount they otherwise could have gotten.

Fees for the plaintiffs’ attorneys will be deducted from the settlement fund, with the remaining money available for payments to consumers. As part of the deal, attorneys for the plaintiffs in the class-action case could get about $16.6 million.

Madison County Associate Judge Ralph Mendelsohn approved the settlement on Oct. 6 and unsealed it Oct. 27. He will hold a hearing March 9 on whether the settlement is fair and whether the plaintiffs’ attorneys are entitled to the fee they request. Messages were left Wednesday with U.S. representatives of London-based GlaxoSmithKline PLC.

Information about the proposed settlement, http://www.paxilpediatricsettlement.com

Please
Click to Register

(read more)

then
Log in
for free access to more features of this website.

Forgot your username or password?

You are invited to
apply for membership
of Healthy Skepticism,
if you support our aims.

Pay a subscription

Support our work with a donation

Buy Healthy Skepticism T Shirts

If there is something you don't like, please tell us. If you like our work, please tell others.

Announcements

PharmedOut’s annual conference: Missing The Target: When Practitioners Harm More Than Heal

No Free Lunch is merging with Healthy Skepticism

Conference program: Pharma Knows Best? Managing Medical Knowledge

Prescrire’s proposals for France’s national conference on medicines policy

Pharmed Out Conference ‘Pharma Knows Best? Managing Medical Knowledge’

More announcements

What's new on this site

Library Home

Library Search

Far too large a section of the treatment of disease is to-day controlled by the big manufacturing pharmacists, who have enslaved us in a plausible pseudo-science...
The blind faith which some men have in medicines illustrates too often the greatest of all human capacities - the capacity for self deception...
Some one will say, Is this all your science has to tell us? Is this the outcome of decades of good clinical work, of patient study of the disease, of anxious trial in such good faith of so many drugs? Give us back the childlike trust of the fathers in antimony and in the lancet rather than this cold nihilism. Not at all! Let us accept the truth, however unpleasant it may be, and with the death rate staring us in the face, let us not be deceived with vain fancies...
we need a stern, iconoclastic spirit which leads, not to nihilism, but to an active skepticism - not the passive skepticism, born of despair, but the active skepticism born of a knowledge that recognizes its limitations and knows full well that only in this attitude of mind can true progress be made.
- William Osler 1909